Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 December, 2014 10:37 IST
Panacea ties with Kremers for 11 high entry barrier generics
Source: IRIS | 19 Nov, 2012, 12.06PM
Comments  |  Post Comment

Panacea Biotec, India's highly progressive research based health managment company has entered into a strategic alliance with Kremers Urban Inc. for 11 high barrier to entry generice, whose market size in US at the innovator level is around USD 4 billion.

The first product in this portfolio is to reach the market in Tacrolimus Capsules that is being launched in US in Nov 2012.

Commenting on the development, Rajesh Jain managing director, Panacea Biotech (Q,N,C,F)* said, ''Panacea Biotech's proven track record in building strong, collaborative working relationship is a key driver for this strategic alliance with Kremers Under that will accelerate the company's growth plans in the US. Approval of Tacrolimus from US-FDA is the first milestone achieved in Panacea Biotec's long term plans for USA; the largest pharmaceutical market in the world. This would be followed by a series of high barrier to entry generic product launches that are being developed by the company. The commercialization strength of Kremars Urban for high barrier to entry generics perfectly synergizes with Panacea Biotec's research, development and manufacturing capabilities for such complex products forming a true win-win strategic alliance.''

Shares of Panacea Biotec gained Rs 8.1, or 7.64%, to trade at Rs 114.10. The total volume of shares traded was 29,308 at the BSE (12.01 p.m., Monday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
CRISIL assigns fundamental grade 4/5 to JSW Steel - 19-Dec-2014 16:18
Emkay maintains `Buy` on L&T - 19-Dec-2014 15:43
Panacea Biotec join hands with Rising Pharmaceuticals - 19-Dec-2014 11:59
Petron Engineering gets LoI for contract worth Rs 240 mn - 19-Dec-2014 11:49
Dr Reddy's closes acquisition of Habitrol brand from Novartis - 19-Dec-2014 11:29
JET Airways introduces 12 additional domestic frequencies - 19-Dec-2014 10:56
Balaji Telefilms joins Indus Media to enter American television market - 19-Dec-2014 10:38
Punj Lloyd gets FIPB nod for manufacture of defence items - 18-Dec-2014 19:17
FIIs can invest up to 100% in Crompton Greaves: RBI - 18-Dec-2014 18:57
FIIs can invest up to 49% in Tree House Education: RBI - 18-Dec-2014 18:40
Logistics companies to be biggest beneficiaries of GST: Allcargo Logistics - 18-Dec-2014 16:40
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer